Historique
Auteur A. R. LLOYD
Documents disponibles écrits par cet auteur (6)
Ajouter le résultat à votre sélection Affiner la recherche
C. TRELOAR ; L. MCCREDIE ; A. R. LLOYD | 2015
Dans Harm Reduction Journal (Vol.12, n°10, 2015) Article : PériodiqueAIM: The potential for transmission of hepatitis C virus (HCV) in prison settings is well established and directly associated with sharing of injecting and tattooing equipment, as well as physical violence. This study is one of the first to exam[...]
S. J. WALKER ; L. B. SHRESTHA ; A. R. LLOYD ; O. DAWSON ; Y. SHEEHAN ; J. SHEEHAN ; N. B. C. MADUKA ; J. CABEZAS ; M. J. AKIYAMA ; N. KRONFLI ; INHSU Prisons | 2024
Dans International Journal of Drug Policy (Vol.126, April 2024) Article : PériodiqueBackground: Carceral settings are a key focus of the 2030 WHO global hepatitis C virus (HCV) elimination goals. Despite this, access to HCV testing and treatment services in prisons remains low globally, limiting opportunities to achieve these g[...]
N. A. BRETANA ; R. R. GRAY ; E. B. CUNNINGHAM ; B. BETZ-STABLEIN ; R. RIBEIRO ; F. GRAW ; F. LUCIANI ; A. R. LLOYD | 2020
Dans Addiction (Vol.115, n°5, May 2020) Article : PériodiqueBACKGROUND AND AIMS: Australia is currently on track to meet the World Health Organization (WHO) global hepatitis C virus (HCV) elimination goals by 2030, reflecting universal subsidized access to testing and direct-acting antiviral (DAA) treatm[...]
J. GREBELY ; G. ROBAEYS ; P. BRUGGMANN ; A. AGHEMO ; M. BACKMUND ; J. BRUNEAU ; J. BYRNE ; O. DALGARD ; J. J. FELD ; M. HELLARD ; M. HICKMAN ; A. KAUTZ ; A. LITWIN ; A. R. LLOYD ; S. MAUSS ; M. PRINS ; T. SWAN ; M. SCHAEFER ; L. E. TAYLOR ; G. J. DORE | 2023
Dans International Journal of Drug Policy (Vol.111, January 2023) Article : PériodiqueDans les pays à revenus élevés, la majorité des infections par le virus de l'hépatite C (VHC) nouvelles et existantes se produisent chez usagers de drogues par injection (UDI). Dans de nombreux pays à revenus faibles et moyens, de vastes épidémi[...]Nouveauté![Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs [Commentary]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_79380.webp)
J. GREBELY ; J. BRUNEAU ; J. V. LAZARUS ; O. DALGARD ; P. BRUGGMANN ; C. TRELOAR ; M. HICKMAN ; M. HELLARD ; T. ROBERTS ; L. CROOKS ; H. MIDGARD ; S. LARNEY ; L. DEGENHARDT ; H. ALHO ; J. BYRNE ; J. F. DILLON ; J. J. FELD ; G. FOSTER ; D. GOLDBERG ; A. R. LLOYD ; J. REIMER ; G. ROBAEYS ; M. TORRENS ; N. WRIGHT ; I. MAREMMANI ; B. L. NORTON ; A. H. LITWIN ; G. J. DORE ; International Network on Hepatitis in Substance Users | 2017
Dans International Journal of Drug Policy (Vol.47, September 2017) Article : PériodiqueGlobally, it is estimated that 71.1 million people have chronic hepatitis C virus (HCV) infection, including an estimated 7.5 million people who have recently injected drugs (PWID). There is an additional large, but unquantified, burden among th[...]
L. LAFFERTY ; F. L. ALTICE ; F. LEONE ; M. STOOVE ; A. R. LLOYD ; B. HAJARIZADEH ; N. KRONFLI | 2024
Dans International Journal of Drug Policy (Vol.131, September 2024) Article : PériodiqueBackground: Prison needle exchange programs (PNEPs) are a critical component for harm reduction in prisons. Little is known about the PNEP access barriers for people who are incarcerated, but the low uptake in the Canadian program highlights the[...]
